![]() ![]() 17944 in six different media, (ii) identification of a medium enabling the production of 1 as essentially the sole metabolite and with improved titer, and (iii) isolation and structural elucidation of three new TAM congeners, H ( 6), I ( 7) and J ( 8), shedding new insights into the structure–activity relationship of 1 as a BmAsnRS inhibitor and an antifilarial drug lead.Ĭloning of tamI from and development of a genetic system for S. Here we now report (i) the comparison of metabolite profiles of S. 6 In this study, we sought out medium optimization to increase 1 titer and to produce 1 as the major metabolite to facilitate the production and isolation of sufficient quantities of 1 for further mechanistic and preclinical studies, in an effort to advance the candidacy of 1 as an antifilarial drug lead. Preliminary fermentation optimization improved 1 production, but still with TAM A ( 2) as the major metabolite together with TAM E ( 3), F ( 4) and G ( 5) as co-metabolites. Under the original fermentation condition using the ISP-2 medium, 1 was produced as a minor metabolite of S. malayi parasites at low nanomolar concentrations yet are not cytotoxic to human hepatic cells. 9078, 7 as promising antifilarial drug leads that kill the adult B. 17944 6 and the depsipeptide WS9326D from Streptomyces sp. 5 Subsequent bioassay-guided dereplication of two of the active strains resulted in the discovery of two natural product scaffolds, represented by tirandamycin (TAM) B ( 1) from Streptomyces sp. malayi AsnRS ( BmAsnRS), we recently completed a high-throughput screening campaign of ∼73 000 microextracts, from a collection of 36 720 microbial strains, for activity against the recombinant BmAsnRS. 2, 3, 4, 5 As part of a drug-discovery program targeting B. malayi is considered an excellent antifilarial target because (i) it is highly expressed in all stages of the parasite life cycle, (ii) it is biochemically and structurally well characterized and (iii) it shows significant structural differences in comparison with human and other eukaryotic aminoacyl-tRNA synthetases. 1 The asparaginyl-tRNA synthetase (AsnRS) in B. Lymphatic filariasis, also known as elephantiasis, is caused primarily by two related parasites, Brugia malayi and Wuchereria bancrofti, and represents a worldwide health crisis with over 200 million people infected and another 20% of the global population at risk of infection. The current study also serves as an excellent reminder that traditional medium and fermentation optimization should continue to be very effective in improving metabolite flux and titer. These findings shed new insights into the structure–activity relationship of TAM B as a BmAsnRS inhibitor, highlighting the δ-hydroxymethyl-α,β-epoxyketone moiety as the critical pharmacophore, and should greatly facilitate the production and isolation of sufficient quantities of TAM B for further mechanistic and preclinical studies to advance the candidacy of TAM B as an antifilarial drug lead. 17944 in six different media, (ii) identification of a medium enabling the production of TAM B as essentially the sole metabolite, and with improved titer, and (iii) isolation and structural elucidation of three new TAM congeners. ![]() ![]() We now report (i) the comparison of metabolite profiles of S. malayi parasites and does not exhibit general cytotoxicity to human hepatic cells. 17944 as a Brugia malayi AsnRS ( BmAsnRS) inhibitor that efficiently kills the adult B. We have recently isolated tirandamycin (TAM) B from Streptomyces sp.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |